Sexual Dysfunction in Aging Men With Lower Urinary Tract Symptoms

Similar documents
Evaluation of Sexual Dysfunction in Lower Urinary Tract Symptoms/Benign Prostatic Hyperplasia Patients

A prospective study of sexual dysfunction in patients with benign prostatic hyperplasia

Lower UrinaryTract Symptoms (LUTS) and Sexual Function in Both Sexes

NOTE: This policy is not effective until April 1, Transurethral Water Vapor Thermal Therapy of the Prostate

MMM. Topic The use of Tadalafil 5mg daily for the treatment of BPH-LUTS

Title of Research Thesis:

Impact of Lower Urinary Tract Symptoms/Benign Prostatic Hyperplasia Treatment with Tamsulosin and Solifenacin Combination Therapy on Erectile Function

REVIEW Validated questionnaires for assessing sexual dysfunction and BPH/LUTS: solidifying the common pathophysiologic link

Increase of Framingham cardiovascular disease risk score is associated with severity of lower urinary tract symptoms

The effect of a temporary prostatic stent on sexual function

EVALUATION OF THE EFFICACY OF TADALAFIL IN IMPROVING LOWER URINARY TRACT SYMPTOMS IN PATIENTS WITH SYMPTOMATIC BENIGN PROSTATIC ENLARGEMENT

Effects of Tamsulosin on Premature Ejaculation in Men with Benign Prostatic Hyperplasia

Sexual dysfunction in male LUTS. M. Gacci Department of Urology, University of Florence

Effects of Low-Dose Tamsulosin on Sexual Function in Patients With Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia

H6D-MC-LVHR Clinical Study Report Synopsis Page LVHR Synopsis (LY450190)

Sexual Function after Transurethral Resection of the Prostate (TURP): Results of an Independent Prospective Multicentre Assessment of Outcome

Erectile dysfunction after transurethral prostatectomy for lower urinary tract symptoms: results from a center with over 500 patients

ClinicalTrials.gov Identifier: sanofi-aventis. Sponsor/company:

The Journal of International Medical Research 2012; 40:

Silodosin versus naftopidil for the treatment of benign prostatic hyperplasia: A multicenter randomized trial

BPH: a present and future perspective on health impact

The impact of overactive bladder on quality of life in south of China

Ejaculation. Emission. Ejection. Orgasm

Shrestha A, Chalise PR, Sharma UK, Gyawali PR, Shrestha GK, Joshi BR. Department of Surgery, TU Teaching Hospital, Maharajgunj, Kathmandu, Nepal

Treating BPH: Comparing Rezum UroLift and HoLEP

Male LUTS, OAB, Sex: natural history. JR Sathiya

Erectile Dysfunction in Men with and without Lower Urinary Tract Symptoms in Nigeria

JMSCR Vol 05 Issue 07 Page July 2017

Validation and Reliability of a Thai Version of the International Index of Erectile Dysfunction (IIEF) for Thai Population

Assessment of Erectile and Ejaculatory Function after Penile Prosthesis Implantation

Last Review Status/Date: December Summary

Conclusions. Keywords

AssociationbetweenSocieoeconomicVariablesSEVandBenignProstaticHyperplasiaBPHamongSudanesePatients

for ED and LUTS/BPH Pierre Sarkis, M.D. Assistant Professor Fellow of the European Board of Urology

The Global Online Sexuality Survey (GOSS) 2015: Erectile Dysfunction Among English-Speaking Internet Users in the United States

Men s Lower Urinary Tract Symptoms Are Also Mental and Physical Sufferings for Their Spouses

FEP Medical Policy Manual

NIH Public Access Author Manuscript J Urol. Author manuscript; available in PMC 2010 May 4.

The Enlarged Prostate Symptoms, Diagnosis and Treatment

Combination Drug Therapy for Benign Prostatic Hyperplasia (BPH)

Prevalence of Benign Prostatic Hyperplasia on Jeju Island: Analysis from a Cross-sectional Community-based Survey

RELATIONSHIPS BETWEEN AMERICAN UROLOGICAL ASSOCIATION SYMPTOM INDEX, PROSTATE VOLUME, PATIENTS WITH BENIGN PROSTATIC HYPERPLASIA

Depression and lower urinary tract symptoms: Two important correlates of erectile dysfunction in middle-aged men in Hong Kong, China

Impact of smoking on Lower Urinary Tract Symptoms (LUTS) - Single tertiary centre experience

Daofang Zhu, Xianming Dou, Liang Tang, Dongdong Tang, Guiyi Liao, Weihua Fang, and Xiansheng Zhang

Can men with prostates sized 80 ml or larger be managed conservatively?

Prostate Gland Volume and Its Relationship to Complications of Benign Prostatic Enlargement

PRABHAKAR SINGH*, MANOJ INDURKAR, AMITA SINGH, PALLAVI INDURKAR

VOIDING DYSFUNCTION IN ELDERLY MALE CURRENT STATUS

Family History and Age at the Onset of Upper Urinary Tract Calculi

FEP Medical Policy Manual

A SURVEY ON LOWER URINARY TRACT SYMPTOMS (LUTS) AMONG PATIENTS WITH BENIGN PROSTATIC HYPERPLASIA (BPH) IN HOSPITAL UNIVERSITI SAINS MALAYSIA (HUSM)

Ambulatory Try off Catheter (ATOC) Program for the Patient with Acute Retention of Urine Outpatient Service

Original Article - Sexual Dysfunction

REPORTS. Clinical and Economic Outcomes in Patients Treated for Enlarged Prostate

Chapter 4: Research and Future Directions

Subject: Temporary Prostatic Stent and Prostatic Urethral Lift

Will Medical Management of Benign Prostatic Hyperplasia Result in Better or Worse Sexual Function in Men?

National Institute for Health and Care Excellence. Lower Urinary Tract Symptoms Update Addendum Consultation Table 3 rd February 5 pm 3 rd March 2015

Index. urologic.theclinics.com. Note: Page numbers of article titles are in boldface type.

PATIENT INFORMATION 2017 NeoTract, Inc. All rights reserved. Printed in the USA. MAC Rev A

Erectile Dysfunction (ED) is Prevalent, Bothersome and Underdiagnosed in Patients Consulting Urologists for Benign Prostatic Syndrome (BPS)

Key words: Lower Urinary Tract Symptoms (LUTS), Prostatic Hyperplasia, Alpha-1 Adrenoceptor Antagonists, Tamsulosin, Terazosin.

Increasing Awareness, Diagnosis, and Treatment of BPH, LUTS, and EP

Does Metabolic Syndrome Increase Erectile Dysfunction and Lower Urinary Tract Symptoms?

OVER 70% OF MEN IN THEIR 60s HAVE SYMPTOMS OF BPH 1

A unit of International Journal Foundation Page I 96

INJINTERNATIONAL. Sociodemographic Factors Related to Lower Urinary Tract Symptoms in Men: A Korean Community Health Survey.

α-blocker Monotherapy and α-blocker Plus 5-Alpha-Reductase Inhibitor Combination Treatment in Benign Prostatic Hyperplasia; 10 Years Long-Term Results

The Relationship between Prostate Inflammation and Lower Urinary Tract Symptoms: Examination of Baseline Data from the REDUCE Trial

Caspian Journal of Reproductive Medicine

IS THERE A RELATIONSHIP BETWEEN ALCOHOL/DRUG ABUSE AND LUTS/ED?

Outcomes of Radical Prostatectomy in Thai Men with Prostate Cancer

Lower urinary tract symptoms in older men: does it predict the future? Bouwman, Iris Ingeborg

Erectile Dysfunction and Comorbidities in Aging Men: An Urban Cross-Sectional Study in Malaysia

Prostatitis: overview and assessment of pain outcomes and implications for inclusion criteria. Michel Pontari IMMPACT-XX Meeting July 13, 2017

Original Policy Date

Office Management of Benign Prostatic Enlargement

The use of the simplified International Index of Erectile Function (IIEF-5) as a diagnostic tool to study the prevalence of erectile dysfunction

MANAGING BENIGN PROSTATIC HYPERTROPHY IN PRIMARY CARE DR GEORGE G MATHEW CONSULTANT FAMILY PHYSICIAN FELLOW IN SEXUAL & REPRODUCTIVE HEALTH

The Hallmarks of BPH Progression and Risk Factors

Benign Prostatic Hyperplasia (BPH):

Benign Prostatic Hyperplasia. Jay Lee, MD, FRCSC Clinical Associate Professor University of Calgary

Prostatic Urethral Lift

Early-Stage Clinical Experiences of Holmium Laser Enucleation of the Prostate (HoLEP)

Prostatic Urethral Lift Corporate Medical Policy

김준철 가톨릭대학교의과대학비뇨기과학교실

Therapeutic Strategies for Managing BPH Progression

INJINTERNATIONAL. Original Article INTRODUCTION

NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE

ORIGINAL ARTICLE. Keywords: doxazosin GITS; erectile dysfunction; IPSS; lower urinary tract symptoms; quality of life; sildenafil

Korean Urologist s View of Practice Patterns in Diagnosis and Management of Benign Prostatic Hyperplasia: A Nationwide Survey

Benign Prostatic Hyperplasia: Update on Innovative Current Treatments

ORIGINAL ARTICLE. WJ Bang 1,CYOh 1,CYoo 1, JS Cho 1, DY Yang 1,DHLee 2, SH Lee 2 and BH Chung 2

Lower urinary tract symptoms in older men: does it predict the future? Bouwman, Iris Ingeborg

Finland and Sweden and UK GP-HOSP datasets

Influence of body mass index on Benign Prostatic Hyperplasia-related complications in patients undergoing prostatectomy

Introduction to PAE. Rational / Animal. Francisco Cesar Carnevale MD, PhD. University of Sao Paulo Medical School - Brazil

Prevalence of Prostatitis-Like Symptoms in Singapore: A Population-Based Study

Transcription:

Sexual Dysfunction and Infertility Sexual Dysfunction in Aging Men With Lower Urinary Tract Symptoms Darab Mehraban, Gholam Hossein Naderi, Seyed Reza Yahyazadeh, Mahdi Amirchaghmaghi Introduction: Our aim was to evaluate the relationship between lower urinary tract symptoms (LUTS), age, and sexual dysfunction in the Iranian men aged 50 to 80 years. Materials and Methods: A total of 357 men aged 50 to 80 years presenting at the urological clinic were enrolled in this study. The International Prostatic Symptom Score (IPSS) and the International Index of Erectile Function (IIEF) questionnaires were used to assess the LUTS and sexual function, respectively. The questionnaires were completed by face-to-face interview. Logistic regression model was used for multivariate analysis of the risk factors of sexual dysfunction and its domains assessed by the IIEF. Results: Of the patients, 332 (93%) were sexually active with a median sexual attempts of 4.6 times per month. Frequency of sexual attempts was inversely related to LUTS severity (P <.001). Advanced age was positively associated with LUTS severity (r = 0.534, P <.001). Sexual dysfunction, defined as IIEF score of 20 and less, was present in 68.2% of the patients. All IIEF domain scores and the overall score were correlated with age (P <.001) and the IPSS (P <.001). In a multivariate analysis, age, diabetes mellitus, and the IPSS were strong independent predictors of the overall IIEF score. Conclusion: Sexual activity as an important component of the quality of life continues in the majority of men over 50 years. However, their sexual function can be severely affected by LUTS and its severity. Keywords: sexual dysfunction, prostatic hyperplasia, aged, urination disorders Department of Urology, Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran Corresponding Author: Department of Urology, Shariati Hospital, Karegar St, Tehran, Iran Tel: +98 912 119 6097 Fax: +98 21 8863 3039 E-mail: darabm@gmail.com Received April 2008 Accepted July 2008 INTRODUCTION Lower urinary tract symptoms (LUTS), mainly caused by benign prostatic hyperplasia (BPH), and sexual dysfunction (SD) are highly prevalent urologic problems among the aging male population. Both conditions have significant impact on the overall quality of life. (1) The Massachusetts male aging study showed that 34.8% of 40- to 70- year-old men suffer from moderate to severe erectile dysfunction. In Iran, impotence was reported in 47% of men aged between 60 and 70 Urol J. 2008;5:260-4. www.uj.unrc.ir years. (2) The condition is strongly related to age, cardiovascular diseases, depression, and diabetes mellitus. (2) Although evidence on the relationship between LUTS and SD are controversial, (3,4) some have shown LUTS to be an independent risk factor of SD. Results of a recent study indicated improvement in LUTS following the treatment of SD. (5) Sexual dysfunction is a complex phenomenon not limited only to erectile dysfunction. It is well 260 Urology Journal Vol 5 No 4 Autumn 2008

established from several clinical studies that ejaculatory disorders are as prevalent as erectile dysfunction, affecting half of men aged over 50 years. (6) Moreover, recent data from the multinational survey of the aging male (MSAM-7), conducted in the United States and 6 European countries, revealed that 46% of men had a reduced amount of ejaculate, and 59% of these men considered it to be a problem. (6) In addition, it was found that ejaculatory disorders significantly increased with the severity of LUTS. (7) Reports from different countries have shown a wide range of incidence of SD in different populations. (8) Meanwhile, some mechanisms such as activation of the noradrenergic system in bladder outlet obstruction or local effects of the enlarged prostate on cavernosal nerves have been proposed to explain this coexistence, but the exact pathophysiology of this relation is unknown. (6) We conducted a cross-sectional study to provide a preliminary sketch of basic epidemiologic data on the frequency of sexual dysfunction and lower urinary tract symptoms in our aging patients and to assess their relationship. MATERIALS AND METHODS Between June 2004 and December 2006, we enrolled 357 men aged 50 to 80 years in this study. Data were collected from the patients referring to the outpatient urological clinic at Shariati Hospital. Those with documented history of bladder calculus, urethral stricture, bladder tumor, prostate cancer, and those with indwelling catheters were excluded. During the outpatient visits, demographic characteristics, comorbidities (diabetes mellitus, hypertension, and hyperlipidemia), life style factors (smoking, alcohol consumption), and history of any pelvic surgery, related traumas, or treatment were asked. Sexual dysfunction and LUTS were assessed by the international index of erectile function (IIEF) and the international prostatic symptom score (IPSS) questionnaires, respectively, completed by face-to-face interview. (9,10) The interviews were performed by trained urology residents in this center. Both questionnaires were linguistically validated using translation and back-translation process. The IPSS questionnaire, is a validated 8-item questionnaire for assessment of the severity of LUTS. The first 7 questions are scored from zero to 5 with an overall score of zero to 35. The severity of symptoms is classified as mild, moderate, and severe for scores of 7 and less, 8 to 19, and more than 20, respectively. The IIEF questionnaire, as the gold standard method for assessment of sexual function in clinical trials, scores separate domains of erectile function, orgasmic function, sexual desire, intercourse satisfaction, and overall satisfaction. We analyzed the relation of the patients IIEF and IPSS scores. Statistical analyses were done using the SPSS software (Statistical Package for the Social Sciences, version 13.0, SPSS Inc, Chicago, Ill, USA). For comparisons between groups, the chisquare test and the Kruskal-Wallis test were used. Correlations were tested with the Spearman rho test. Multivariate analysis using logistic regression model was used to measure the relationship between LUTS and sexual dysfunction, adjusted for confounding factors. Two-sided test with type 1 error of 5% and 95 % confidence interval was used. RESULTS All of the approached 357 eligible patients consented to participate in the study. The mean age of the patients was 64.1 ± 7.4 years (range, 50 to 80 years). Table 1 summarizes the clinical characteristics of the respondents. The median IPSS score was 15 and in terms of severity, 68 (19.0%), 188 (52.7%), and 98 (27.5%) patients had mild, moderate, and severe LUTS, respectively. Logistic regression analysis showed Table 1. Characteristics of Patients With Lower Urinary Tract Symptoms (n = 357) Characteristics Patients (%) Missed Data (%) Comorbidities Diabetes mellitus 49 (13.7) 1 (0.3) Hypertension 96 (26.9) 12 (3.4) Hyperlipidemia 48 (13.7) 7 (1.9) Life style factors Smoking 102 (28.6) 1 (0.3) Alcohol consumption 3 (0.8) 0 History of pelvic trauma 13 (3.6) 40 (11.2) History of pelvic surgery 18 (5.0) 44 (12.3) Urology Journal Vol 5 No 4 Autumn 2008 261

a significant association between the age and severity of LUTS (r = 0.534, P <.001). The association of other variables with the IPSS are shown in Table 2. Of the participants, 332 (92.9%) were sexually active, reporting a median monthly sexual attempts of 4.6 times. This rate was significantly lower in those with severe LUTS (P <.001); The median frequency of sexual attempts was 6.4 times per month for the patients with mild symptoms compared to 3.3 times per month for Table 2. Severity of Lower Urinary Tract Symptoms Stratified By Risk Factors* Lower Urinary Tract Symptoms Risk Factors Mild Moderate Severe P Smoking Yes 16 (15.8) 48 (47.5) 37 (36.6) No 52 (20.6) 140 (55.3) 61 (24.1).06 Diabetes mellitus Yes 4 (8.2) 28 (57.1) 17 (34.7) No 64 (21.0) 160 (52.5) 81 (26.6).09 Hypertension Yes 8 (8.4) 50 (52.6) 37 (38.9) No 57 (23.0) 135 (54.4) 56 (22.6).001 History of surgery Yes 2 (11.1) 2 (38.9) 9 (50.0) No 61 (20.8) 156 (53.2) 76 (25.9).11 History of trauma Yes 1 (7.7) 9 (69.2) 3 (23.1) No 62 (20.5) 62 (51.3) 85 (28.1).45 *Numbers in parenthesis are percents. those with severe LUTS. The overall frequency of sexual dysfunction, defined as IIEF scores of 20 or less, was 68.2%. There was a strong relationship between all IIEF domain scores and the severity of LUTS irrespective of other comorbidities such as diabetes mellitus, hypertension, and hyperlipidemia. Similar relations were observed for the age (Tables 3 and 4). Univariate logistic regression analysis revealed that the IPSS (P <.001), age (P <.001), smoking (P <.013), diabetes mellitus (P <.001), and hypertension (P =.001) were associated with the overall IIEF scores. However, on multivariate analysis, only age, diabetes mellitus, and the IPSS were remained in the model. DISCUSSION Lower urinary tract symptoms and sexual dysfunction are age-related conditions that are commonly seen during the routine urologic visits. It has been shown that the prevalence of histologic BPH increases from 8% in the 4th decade to 82% in the 8th decade of life. (11) There might be differences in the prevalence of LUTS in different cultures. A greater rates of LUTS were reported in Japan and the United States in comparison to those in France or Scotland. (12) There has been notable differences in the prevalence of moderate to severe LUTS between men in Singapore (14%) and Philippines (56%). (13) Table 3. Correlation Coefficients for Association of IIEF Domains With IPSS and Age* Associated Factors Overall Overall Satisfaction Intercourse Satisfaction IIEF Domains Scores Sexual Desire Orgasmic Function Erectile Function IPSS score -0.655-0.539-0.487-0.450-0.439-0.659 Age -0.504-0.458-0.330-0.350-0.323-0.516 *IIEF indicates the international index of erectile function and IPSS, the international prostatic symptom score. P <.001; Spearman rho test. Table 4. Scores of IIEF Domains According to Severity of Lower Urinary Tract Symptoms* Lower Urinary Tract Symptoms Domains Mild Moderate Severe P Erectile function 25 (5 to 30) 20 (8 to 29) 13 (1 to 25) <.001 Orgasmic function 8 (4 to10) 6 (0 to 10) 5 (0 to 10) <.001 Sexual desire 7 (3 to 10) 6 (2 to 10) 5 (2 to 9) <.001 Intercourse satisfaction 11 (1 to 15) 9 (4 to 14) 6 (0 to 13) <.001 Overall satisfaction 9 (2 to 10) 7 (2 to 10) 5 (2 to 10) <.001 Overall 59 (24 to 68) 47 (24 to 70) 34 (5 to 64) <.001 *Values are medians (ranges). 262 Urology Journal Vol 5 No 4 Autumn 2008

In a recent report from Sweden, Ströberg and coworkers demonstrated that 45% of the individuals with LUTS had moderate to severe degree of problems. (14) The current study showed that the prevalence of moderate to severe LUTS was 80.1% which was significantly higher than that in other studies. Discrepancies in the LUTS prevalence might be due to cultural differences and the willingness to seek medical help for LUTS and sexual dysfunction. Moreover, our sample was collected from a tertiary center population, leading to a selection bias. Moreover, there has been significant correlation between age and IPSS score which is in accordance with Reggio and colleagues study. (14) Recently, several investigations have examined the association of the components of metabolic syndromes with BPH and suggested that metabolic profile of men constitute a risk factor of the development of BPH. A prospective study showed that only categorized parameters of fasting blood glucose, serum triglyceride, and serum high-density lipoprotein cholesterol correlated with the severity of LUTS. In addition, the researchers did not find any association of LUTS with hypertension, smoking, hyperlipidemia, alcohol consumption, and diabetes mellitus. (16) We did not find such relations between these variables and the IPSS, either. Sexual activity remains high in Iranian men aged 50 to 80 years. This prevalence is rather high compared with men in the southeast of Asia (93% versus 73%). (13) In the MSAM-7, 52% of men aged 40 to 70 years had some degrees of erectile dysfunction ranging from 39% in men aged 40 years to 67% in those aged 70 years. (6) Other studies demonstrated different incidences of sexual dysfunction among different countries. For example, men in Japan (34%) and Malaysia (22%) had higher incidences of moderate to complete erectile dysfunction in comparison with those in Italy (17%) and Brazil (15%). (8) Erectile dysfunction was reported by 68.2% of the men in our study that was significantly higher than these reports. Previous cross-sectional studies have shown that the prevalence of sexual dysfunction is independently increased with the LUTS severity. In a large cohort study on 6000 French men with LUTS, Lukacs and colleagues reported that impairment of patients sexual activity was related to both age and severity of the LUTS, which is in accordance with other studies. (17) The MSAM-7 showed that IPSS score was a highly significant predictor of all the IIEF domain scores. They also showed an independent effect of age and other comorbidities (diabetes, hypertension, cardiac disease, and hyperlipidemia), as well as tobacco use and alcohol consumption, on all the IIEF domain scores. The strongest predictor was age followed by the IPSS score. Likewise, we found a significant association between the LUTS severity and all of the IIEF domain scores. In the present study, in line with the other studies, the IPSS score, age, and diabetes mellitus were strong independent predictors of the overall IIEF score. Although, epidemiological studies provide clear evidence that LUTS and sexual dysfunction are strongly linked, a causal relationship cannot be established by the data from these studies. Even these associations from epidemiological studies must have plausible biochemical explanations to be widely accepted. Reduced production of nitric oxide/nitric oxide synthase in the pelvis and the activation of autonomic system due to bladder outlet obstruction have been proposed as potential mechanisms. (6) However, the exact mechanism has not been understood yet. We could not assess the ejaculatory problems because of lack of validated questionnaires. Limitations of the present study are a rather small sample size compared to similar studies, a selection bias due to recruitment of the patients from a tertiary center, and finally, the crosssectional nature of this study which limits its strength to establish a causal relationship. On the other hand, data in our study were collected by face-to-face interview. This method increases the reliability of our data. To our knowledge, this is the first study examining sexual dysfunction in relation to LUTS in the Middle East. CONCLUSION Elderly men, especially those with LUTS, should be routinely asked about their sexual function. Erectile dysfunction is prevalent in these patients Urology Journal Vol 5 No 4 Autumn 2008 263

and is also strongly related to the severity of the symptoms. Sexual dyfunction should be considered when treating aging men with LUTS. FINANCIAL SUPPORT This study was supported by a medical research grant from Tehran University of Medical Sciences. CONFLICT OF INTEREST None declared. REFERENCES 1. Van Dijk L, Kooij DG, Schellevis FG, Kaptein AA, Boon TA, Wooning M. Nocturia: impact on quality of life in a Dutch adult population. BJU Int. 2004;93:1001-4. 2. Safarinejad MR. Prevalence and risk factors for erectile dysfunction in a population-based study in Iran. Int J Impot Res. 2003;15:246-52. 3. Braun MH, Sommer F, Haupt G, Mathers MJ, Reifenrath B, Engelmann UH. Lower urinary tract symptoms and erectile dysfunction: co-morbidity or typical Aging Male symptoms? Results of the Cologne Male Survey. Eur Urol. 2003;44:588-94. 4. Akkus E, Kadioglu A, Esen A, et al; Turkish Erectile Dysfunction Prevalence Study Group. Prevalence and correlates of erectile dysfunction in Turkey: a population-based study. Eur Urol. 2002;41:298-304. 5. McVary KT. Sexual function and alpha-blockers. Rev Urol. 2005;7:s3-11. 6. Rosen R, Altwein J, Boyle P, et al. Lower urinary tract symptoms and male sexual dysfunction: the multinational survey of the aging male (MSAM-7). Eur Urol. 2003;44:637-49. 7. McVary KT. Sexual dysfunction in men with lower urinary tract symptoms and benign prostatic hyperplasia: an emerging link. BJU Int. 2003;91:770-1. 8. Nicolosi A, Moreira ED Jr, Shirai M, Bin Mohd Tambi MI, Glasser DB. Epidemiology of erectile dysfunction in four countries: cross-national study of the prevalence and correlates of erectile dysfunction. Urology. 2003;61:201-6. 9. Barry MJ, Fowler FJ Jr, O Leary MP, et al. The American Urological Association symptom index for benign prostatic hyperplasia. The Measurement Committee of the American Urological Association. J Urol. 1992;148:1549-57. 10. Rosen RC, Cappelleri JC, Gendrano N 3rd. The International Index of Erectile Function (IIEF): a stateof-the-science review. Int J Impot Res. 2002;14:226-44. 11. Berry SJ, Coffey DS, Walsh PC, Ewing LL. The development of human benign prostatic hyperplasia with age. J Urol. 1984;132:474-9. 12. Girman CJ, Jacobsen SJ, Tsukamoto T, et al. Healthrelated quality of life associated with lower urinary tract symptoms in four countries. Urology. 1998;51:428-36. 13. Li MK, Garcia LA, Rosen R. Lower urinary tract symptoms and male sexual dysfunction in Asia: a survey of ageing men from five Asian countries. BJU Int. 2005;96:1339-54. 14. Reggio E, de Bessa J Jr, Junqueira RG, et al. Correlation between lower urinary tract symptoms and erectile dysfunction in men presenting for prostate cancer screening. Int J Impot Res. 2007;19:492-5. 15. Ströberg P, Boman H, Gellerstedt M, Hedelin H. Relationships between lower urinary tract symptoms, the bother they induce and erectile dysfunction. Scand J Urol Nephrol. 2006;40:307-12. 16. Paick JS, Yang JH, Kim SW, Ku JH. Are age, anthropometry and components of metabolic syndrome-risk factors interrelated with lower urinary tract symptoms in patients with erectile dysfunction? A prospective study. Asian J Androl. 2007;9:213-20. 17. Lukacs B, Leplège A, Thibault P, Jardin A. Prospective study of men with clinical benign prostatic hyperplasia treated with alfuzosin by general practitioners: 1-year results. Urology. 1996;48:731-40. 264 Urology Journal Vol 5 No 4 Autumn 2008